Pharmaceutical Concerns

Michaelis-Menten and Lineweaver-Burk plots can help classify an inhibitor, but successful drug development requires the ability to compare the effectiveness of one inhibitor to another based on results from an assay. Enzymes are typically compared based on one of two values K or IC5(). 

K is the inhibition constant and corresponds to the dissociation equilibrium constant of an enzyme-inhibitor complex. /C50 is the concentration of the inhibitor required to decrease the enzyme rate by 50%. Smaller K and IC50 values are both indicative of a stronger inhibitor. 

The y-intercept is the original Km of the substrate with no inhibitor. The theoretical x-intercept is —K. The slope is Km/K with Km being the uninhibited Km (not V°bs). This type of calculation only works for competitive inhibitors and requires multiple experiments, each performed with a different concentration of inhibitor ([I]). 

PROBLEM The following table presents some. K°bs-[I] data points for a competitive, reversible inhibitor of an enzyme. Km for the substrate of the uninhibited enzyme is 10 mM. What is the K of the inhibitor  

Despite being easier to determine and therefore more amenable for use with high-throughput screening, IC50 values do have problems. An /C50 value depends on the conditions of the inhibition experiment, namely the concentration of the substrate. If more substrate is used in the experiment, then more inhibitor will be required to suppress the 

---

WHO can advise UNICH and other UN agencies whether vaccines and other medicines included in die prequaUfication scheme effectively meet WHO-recommended requirements only if die national regulatory audiority of die producing country exercises independent and appropriate oversight of die pharmaceuticals concerned, and if they have been adequately assessed by diat authority (WHO, 2002). 

Adams JD, Flora KR Goldspiel BR, Wilson JW, Arbuck SG, Finley R. Taxol a history of pharmaceutical development and current pharmaceutical concerns. J Natl Cancer Inst Monogr 1993 15 141-147. 

When organic (drug) molecules crystallize from a solvent, the crystal structure is dependent upon the speed of crystallization, temperature, polarity of the solvent, concentration of the material, etc. Since the energy of the crystal affects the (physiological) rate of dissolution and thus the potency and activity of the drug, polymorphism is an important pharmaceutical concern [39]. The most common tool to determine crystal form is differential scanning calorimetry (DSC). Unfortunately, DSC uses small samples and may not represent the bulk of the material. X-ray diffraction is another excellent technique, but quite slow and sometimes difficult to interpret. 

While masterbatching systems have received little attention to date, there is now awareness of the importance of various constituents such as carriers of a similar plastic but of a different MFT, different types of plastic, paraffins, oils, etc., and certain added lubricants, etc. Even though they are present at low levels after dilution, knowledge is becoming more relevant. As an important step in knowing the constituents of a plastic, details on the master batch should therefore be included. Using a reputable masterbatcher (i.e. one aware of pharmaceutical concerns) overcomes the above risks. 

Part 2 presents 26 monographs of Tc pharmaceuticals, concerning the preparation and safe clinical application. Each monograph provides information on the characteristics of the radiotracer based on chemistry, factors affecting the preparation and in vivo stability, pharmacokinetics and elimination properties, as well as details concerning the clinical application. For each clinical procedure, the effective radiation dose of the patient has been calculated. Methods recommended for quality control and actual results are included. 

Recall The decision taken by a pharmaceutical concern to recall ail or part of the batches of a medicine which has been distributed. 

The development of a new drug is both a time-consuming and a cost-intensive process. It takes 12 to 15 years and costs up to 800 million to bring a new drug to the market. As measured by the market capitalization, the pharmaceutical companies play a pivotal role in the global economy. In February 2003 Pfizer was ranked at position five worldwide, with a market capitalization of 163 billion. Ranking third as far as the market capitalization in Europe is concerned was GlaxoSmithKline, with a current value of 101 billion. Novartis was number five in Europe with 82 billion. 

Chiral separations are concerned with separating molecules that can exist as nonsupetimposable mirror images. Examples of these types of molecules, called enantiomers or optical isomers are illustrated in Figure 1. Although chirahty is often associated with compounds containing a tetrahedral carbon with four different substituents, other atoms, such as phosphoms or sulfur, may also be chiral. In addition, molecules containing a center of asymmetry, such as hexahehcene, tetrasubstituted adamantanes, and substituted aHenes or molecules with hindered rotation, such as some 2,2 disubstituted binaphthyls, may also be chiral. Compounds exhibiting a center of asymmetry are called atropisomers. An extensive review of stereochemistry may be found under Pharmaceuticals, Chiral. 

Other uses include use as a reaction and extraction solvent in pharmaceutical production as an intermediate for the preparation of catalysts, antioxidants (qv), and perfumes and as a feedstock in the production of methyl isopropenyl ketone, 2,3-butanedione, and methyl ethyl ketone peroxide. Concern has also arisen at the large volume of exported MEK which has been covertly diverted and used to process cocaine in Latin American countries... 

Ammonia H2O2 Initiation. The lower molecular weight grades (K-15 and K-30) ofPVP ate prepared industrially with an ammonia /H O initiation system. Such products ate the standards for the pharmaceutical industry and conform to the various national pharmacopeias. Several papers have appeared concerning the mechanism of this polymerization (15). 

Process Economics. Relative economics of various ceU culture processes depend heavily on the performance of the ceU line in a system and on the cost of raw materials, particularly the medium. Models are usuaUy developed for the various processes using productivity data obtained from smaU-scale experiments (see Pilot AND MiCROPLANTs). Often, for high value products, the process which ensures the shortest time to market may be the process of choice because of other economic criteria. This is especially tme for pharmaceuticals (qv). RehabUity concerns also often outweigh economic considerations in choosing a process for a high value product. 

Industrial refrigeration - New industrial refrigeration systems that are used by the chemical, petrochemical, pharmaceutical, oil and gas, and metallurgical industries, as well for industrial ice making and for sports and leisure facilities, can use ammonia and hydrocarbons as the refrigerant. Although the product base concerned is small, existing CFC equipment can be retrofitted to use HCFC-22, HFCs and HFC blends, and hydrocarbons. 

ACSH is a consumer education consortium concerned with issues related to food, nutrition, chemicals, pharmaceuticals, lifestyle, the environment and health. ACSH is an independent, nonprofit, tax-exempt organization. 

Side chain reaction in derivatives of compound 2 has largely been concerned with the production of compounds with pharmaceutical activity by reaction between chloroalkyl side chains in position 2 and suitable amines. A selection of such compounds are 224 (82JAP(K)206684), and 225 (81FRP2450259) both are antihypertensive. Use of a dichloromethyl side chain provides an unsaturated amine, as in compound 226 (81FRP2450259). 

The recognition of differences in the pharmacological activity of enantiomeric molecules has created the need to administer them - and therefore to obtain them -as isolated enantiomers. However, nowadays this problem affects not only the pharmaceutical industry, but also the agrochemical industry and food additive producers, both of which are increasingly concerned by this subject. 

---